Assurant vs RenaissanceRe
AIZ and RNR side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AIZ and RNR compare
Assurant and RenaissanceRe are about the same size, with market caps of $14.4B and $14.1B.
On earnings, RenaissanceRe is cheaper: it trades at 5.8× trailing earnings, against 13.9× for Assurant.
Assurant grew revenue faster over the last twelve months (9.4% versus −14.0% for RenaissanceRe).
RenaissanceRe keeps more of each dollar of sales as profit, with a net margin of 23.7% compared with 7.9% at Assurant.
Both pay dividends: Assurant yields 1.2% and RenaissanceRe 0.36%.
Assurant scores higher on the StockData Score (15 against 13 for RenaissanceRe), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AIZ | RNR |
|---|---|---|
| Size and price | ||
| Market cap | $14.4B | $14.1B |
| Share price | $292.80 | $339.32 |
| Change, 1 year | 40.7% | 37.1% |
| Change, 5 years | 80.1% | 122% |
| Beta (5Y) | 0.60 | 0.23 |
| Employees | 15K | 1,040 |
| StockData Score | ||
| Total score | 15 (better) | 13 |
| Valuation score | 2 | 4 (better) |
| Growth score | 4 (better) | 2 |
| Performance score | 5 | 5 |
| Health score | 0 | 0 |
| Dividend score | 4 (better) | 2 |
| Valuation | ||
| P/E | 13.9× | 5.8× (better) |
| P/S | 1.1× (better) | 1.3× |
| P/B | 2.4× | 1.2× (better) |
| EV/EBITDA | 7.5× | 2.9× (better) |
| P/FCF | 8.7× | – |
| PEG | 0.28 | – |
| FCF yield | 11.5% | – |
| Fair value | $237.39 | $433.03 |
| Margin of safety | −23.3% | 21.6% (better) |
| Growth | ||
| Revenue growth (TTM) | 9.4% (better) | −14.0% |
| Revenue growth, 5Y average | 6.0% | 20.0% (better) |
| Net income growth (TTM) | 48.3% (better) | 31.8% |
| EPS growth (TTM) | 51.0% (better) | 50.0% |
| EPS growth, 5Y average | 19.4% | 29.6% (better) |
| Profitability | ||
| Net margin | 7.9% | 23.7% (better) |
| FCF margin | 12.3% | – |
| Return on equity | 18.3% | 23.3% (better) |
| Financial health | ||
| Altman Z-score | 0.86 (better) | 0.72 |
| Piotroski F-score | 7 | 7 |
| Dividends and buybacks | ||
| Dividend yield | 1.2% (better) | 0.36% |
| Payout ratio | 16.6% | 2.7% |
| Years of dividend growth | 16 | – |
| Dividend growth, 5Y average | 5.2% | – |
| Buyback yield | 2.6% | 11.1% (better) |
| Shareholder yield | 3.8% | 11.5% (better) |
| Ownership | ||
| Held by institutions | 98.6% | 100% |
| Held by insiders | 0.79% | 2.4% |
| Insider net buying, 12 months | −$11.0M (better) | −$16.2M |
| Superinvestors holding | – | 2 |
| Short interest, % of float | – | 3.1% |
Go deeper
- AIZ stock overview
- AIZ income statement
- AIZ valuation and score
- RNR stock overview
- RNR income statement
- RNR valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.